Shingrix 0.5ml Im Vial (10 Pack)
Overview
What is this medicine?
How to Use This Medicine
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.
In the event that you miss a dose, contact your doctor to receive guidance on the appropriate course of action.
Lifestyle & Tips
- Maintain good hygiene to prevent infections.
- Report any severe or unusual side effects to your healthcare provider.
- Keep your vaccination record updated.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Guillain-Barre syndrome, a rare nervous system disorder, which may cause:
+ Weakness
+ Burning, numbness, or tingling sensations that are not normal
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms, contact your doctor or seek medical help:
Pain, redness, or swelling at the injection site
Muscle pain
Feeling tired or weak
Headache
Shivering
Fever
Upset stomach or vomiting
Stomach pain or diarrhea
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, don't hesitate to contact your doctor. You can also report side effects to the FDA/CDC Vaccine Adverse Event Reporting System (VAERS) online at https://vaers.hhs.gov/reportevent.html or by calling 1-800-822-7967. Your doctor can provide medical advice about side effects and help you manage any concerns.
Seek Immediate Medical Attention If You Experience:
- Signs of a severe allergic reaction (anaphylaxis) such as difficulty breathing, wheezing, hives, swelling of the face or throat, dizziness, or weakness. Seek immediate medical attention.
- High fever (above 102Β°F or 39Β°C) that does not respond to fever reducers.
- Severe or persistent pain, redness, or swelling at the injection site that worsens or spreads.
- Any new or worsening symptoms after vaccination.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
Potential interactions with other medications or health conditions. To ensure safe use, disclose all medications you are currently taking, including:
+ Prescription medications
+ Over-the-counter (OTC) medications
+ Natural products
+ Vitamins
* Any existing health problems, as they may affect the safety and efficacy of this medication.
To avoid potential interactions, do not start, stop, or modify the dosage of any medication without first consulting your doctor. It is crucial to verify that it is safe to take this medication in conjunction with all your other medications and health conditions.
Precautions & Cautions
If you are pregnant, planning to become pregnant, or are breastfeeding, it is crucial to discuss this with your doctor. You and your doctor will need to weigh the benefits and risks of this medication to both you and your baby.
Overdose Information
Overdose Symptoms:
- No specific symptoms of overdose are known for vaccines, as they are administered in fixed, small doses. However, administration of more than the recommended dose may increase the risk or severity of local or systemic reactions.
What to Do:
Contact a healthcare professional or poison control center (1-800-222-1222) for advice. Symptomatic and supportive care should be provided as needed.
Drug Interactions
Moderate Interactions
- Immunosuppressants (e.g., corticosteroids, chemotherapy, biologics)
Monitoring
Baseline Monitoring
Rationale: To determine eligibility and appropriate dosing schedule.
Timing: Prior to first dose
Rationale: To identify potential contraindications.
Timing: Prior to first dose
Routine Monitoring
Frequency: Within 7 days post-vaccination
Target: Mild to moderate, self-limiting
Action Threshold: Severe or persistent reactions, signs of infection (e.g., pus, spreading redness beyond injection site)
Frequency: Within 7 days post-vaccination
Target: Mild to moderate, self-limiting
Action Threshold: Severe or persistent symptoms, high fever, signs of allergic reaction (e.g., difficulty breathing, hives, swelling of face/throat)
Symptom Monitoring
- Injection site pain
- Injection site redness
- Injection site swelling
- Muscle pain (myalgia)
- Fatigue
- Headache
- Fever
- Shivering
- Gastrointestinal symptoms (nausea, vomiting, diarrhea)
- Rash (rare, but should be reported)
- Signs of allergic reaction (hives, swelling of face/throat, difficulty breathing, dizziness, weakness)
Special Patient Groups
Pregnancy
There are no adequate and well-controlled studies of Shingrix in pregnant women. Shingrix is not a live vaccine, so the theoretical risk to the fetus is low. Vaccination should be considered only if the potential benefits outweigh the potential risks to the mother and fetus. Consult with a healthcare provider.
Trimester-Specific Risks:
Lactation
It is not known whether Shingrix is excreted in human milk. The developmental and health benefits of breastfeeding should be considered along with the motherβs clinical need for Shingrix and any potential adverse effects on the breastfed infant from Shingrix or from the underlying maternal condition. Consult with a healthcare provider.
Pediatric Use
Safety and effectiveness have not been established in individuals younger than 18 years of age. Not indicated for pediatric use.
Geriatric Use
Approved for adults 50 years of age and older. No dose adjustment is required based on age. Efficacy and immunogenicity remain high in older adults, though local and systemic reactions may be slightly more frequent or severe in younger adults (50-69 years) compared to older adults (70+ years).
Clinical Information
Clinical Pearls
- Shingrix is a non-live, recombinant vaccine, making it safe for immunocompromised individuals (unlike the older live zoster vaccine, Zostavax).
- It requires a 2-dose series for full efficacy. Adherence to the dosing schedule (2-6 months apart for general population, 1-2 months for immunocompromised) is crucial for optimal protection.
- Common side effects are injection site reactions (pain, redness, swelling) and systemic symptoms (fatigue, muscle pain, headache), which are usually mild to moderate and resolve within 2-3 days.
- Despite the side effects, the high efficacy (over 90%) and long-lasting protection make it a highly recommended vaccine for eligible individuals.
- Can be co-administered with other routinely recommended adult vaccines (e.g., influenza, tetanus-diphtheria-acellular pertussis [Tdap], pneumococcal) at different injection sites.
Alternative Therapies
- Zostavax (Zoster Vaccine Live): An older, live attenuated vaccine, less effective than Shingrix and not recommended for immunocompromised individuals. No longer marketed in the US as of July 1, 2020.
- Antiviral medications (e.g., acyclovir, valacyclovir, famciclovir): Used for treatment of acute herpes zoster or postherpetic neuralgia, not for prevention.